Skip to Content
Morningstar

Lord Abbett Dividend Growth I LAMYX

Morningstar Medalist Rating
Medalist Rating as of | See Lord Abbett Investment Hub
  • NAV / 1-Day Return 20.84  /  −0.90 %
  • Total Assets 3.8 Bil
  • Adj. Expense Ratio
    0.650%
  • Expense Ratio 0.650%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 0.93%
  • Turnover 35%

USD | NAV as of Apr 16, 2024 | 1-Day Return as of Apr 16, 2024, 12:16 AM GMT+0

Morningstar’s Analysis LAMYX

Will LAMYX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable LAMYX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the LAMYX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of LAMYX’s parent organization’s priorities and whether they’re in line with investors’ interests.

More to prove.

Analyst Drew Carter

Drew Carter

Analyst

Summary

Lord Abbett Dividend Growth’s team has more to prove.

by Drew Carter
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LAMYX

More LAMYX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 37.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

9.01 346.3 Mil
Technology

NVIDIA Corp

4.89 187.7 Mil
Technology

Mastercard Inc Class A

4.00 153.6 Mil
Financial Services

Exxon Mobil Corp

3.63 139.5 Mil
Energy

UnitedHealth Group Inc

2.97 114.3 Mil
Healthcare

Apple Inc

2.90 111.4 Mil
Technology

AbbVie Inc

2.87 110.4 Mil
Healthcare

Eli Lilly and Co

2.68 103.0 Mil
Healthcare

Lam Research Corp

2.47 94.7 Mil
Technology

Accenture PLC Class A

2.41 92.6 Mil
Technology